These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. In vitro susceptibility and in vivo efficacy of antimicrobials in the treatment of Bacteroides fragilis-Escherichia coli infection in mice. Brook I J Infect Dis; 1989 Oct; 160(4):651-6. PubMed ID: 2677161 [TBL] [Abstract][Full Text] [Related]
9. In vitro susceptibility vs. in vivo efficacy of various antimicrobial agents against the Bacteroides fragilis group. Brook I Rev Infect Dis; 1991; 13(6):1170-80. PubMed ID: 1775850 [TBL] [Abstract][Full Text] [Related]
10. The treatment of irradiated mice with polymicrobial infection caused by Bacteroides fragilis and Escherichia coli. Brook I; Ledney GD J Antimicrob Chemother; 1994 Feb; 33(2):243-52. PubMed ID: 8182005 [TBL] [Abstract][Full Text] [Related]
11. Therapy for experimental intraabdominal sepsis: comparison of four cephalosporins with clindamycin plus gentamicin. Louie TJ; Onderdonk AB; Gorbach SL; Bartlett JG J Infect Dis; 1977 Mar; 135 Suppl():S18-22. PubMed ID: 321707 [TBL] [Abstract][Full Text] [Related]
12. Effect of hyperbaric oxygenation, combined with antimicrobial agents and surgery, in a rat model of intraabdominal infection. Muhvich KH; Myers RA; Marzella L J Infect Dis; 1988 May; 157(5):1058-61. PubMed ID: 3283257 [No Abstract] [Full Text] [Related]
13. In vivo efficacy of trovafloxacin against Bacteroides fragilis in mixed infection with either Escherichia coli or a vancomycin-resistant strain of Enterococcus faecium in an established-abscess murine model. Stearne LE; Gyssens IC; Goessens WH; Mouton JW; Oyen WJ; van der Meer JW; Verbrugh HA Antimicrob Agents Chemother; 2001 May; 45(5):1394-401. PubMed ID: 11302801 [TBL] [Abstract][Full Text] [Related]
14. Pathogenicity of capsulate and non-capsulate members of Bacteroides fragilis and B. melaninogenicus groups in mixed infection with Escherichia coli and Streptococcus pyogenes. Brook I J Med Microbiol; 1988 Nov; 27(3):191-8. PubMed ID: 2903934 [TBL] [Abstract][Full Text] [Related]
15. Effect of prophylactic antibiotics upon mixed infections with Bacteroides fragilis. Brook I Surg Gynecol Obstet; 1987 Dec; 165(6):491-5. PubMed ID: 3317944 [TBL] [Abstract][Full Text] [Related]
16. Relative efficacy and critical interval of antimicrobial agents in experimental infections involving bacteroides fragilis. Bartlett JG; Dezfulian M; Joiner K Arch Surg; 1983 Feb; 118(2):181-4. PubMed ID: 6849635 [TBL] [Abstract][Full Text] [Related]
17. Antibiotics fail to prevent abscess formation secondary to bacteria trapped in fibrin clots. Hau T; Jacobs DE; Hawkins NL Arch Surg; 1986 Feb; 121(2):163-8. PubMed ID: 3511886 [TBL] [Abstract][Full Text] [Related]
18. Standardized intraabdominal abscess formation with generalized sepsis: pathophysiology in the rat. Hansson L; Alwmark A; Christensen P; Jeppsson B; Holst E; Bengmark S Eur Surg Res; 1985; 17(3):155-9. PubMed ID: 3888637 [TBL] [Abstract][Full Text] [Related]
19. The efficacy of pefloxacin in comparison to gentamicin in the treatment of experimentally induced peritonitis in rats. Nord CE; Edlund C; Lahnborg G J Antimicrob Chemother; 1986 Apr; 17 Suppl B():59-63. PubMed ID: 2872197 [TBL] [Abstract][Full Text] [Related]
20. An experimental model of intraabdominal abscess in the rat. Fry DE; Garrison RN; Rink RD; Casey J; DeCamp MM; Richardson JD Adv Shock Res; 1982; 7():7-11. PubMed ID: 6753539 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]